The therapeutic potential of interleukin-10 in neuroimmune diseases

Neuropharmacology

Volumn 96, Issue PA, 2015, Pages 55-69

  Kwilasz, A J ^a   Grace, P M ^a   Serbedzija, P ^a   Maier, S F ^a   Watkins, L R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Interleukin 10; Interleukin 10 receptor; Multiple sclerosis; Neuropathic pain; Osteoarthritis; Parkinson's disease

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE A2 RECEPTOR AGONIST; CD209 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; NAKED DNA; PLASMID DNA; POLYMER; STAT3 PROTEIN; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CHROMOSOME 13; DRUG MECHANISM; EPIGENETICS; EXON; FEMALE; GENE THERAPY; GENETIC TRANSCRIPTION; GLIA; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INNATE IMMUNITY; MALE; MOUSE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; OSTEOARTHRITIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RAT; REGULATORY T LYMPHOCYTE; ANIMAL; DRUG DELIVERY SYSTEM; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; NEURALGIA; SIGNAL TRANSDUCTION;

ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; MALE; MULTIPLE SCLEROSIS; NEURALGIA; NEUROIMMUNOMODULATION; OSTEOARTHRITIS; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

EID: 84930927235     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.10.020     Document Type: Review

References (220)

1. N. Alaaeddine, J.A. Di Battista, J.P. Pelletier, K. Kiansa, J.M. Cloutier, and J. Martel-Pelletier Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways Arthritis Rheum. 42 1999 710 718
2. R. Ali, R.S. Nicholas, and P.A. Muraro Drugs in development for relapsing multiple sclerosis Drugs 73 2013 625 650
3. O. Ananieva, J. Darragh, C. Johansen, J.M. Carr, J. McIlrath, J.M. Park, A. Wingate, C.E. Monk, R. Toth, S.G. Santos, L. Iversen, and J.S. Arthur The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling Nat. Immunol. 9 2008 1028 1036
4. A.C. Anderson, J. Reddy, R. Nazareno, R.A. Sobel, L.B. Nicholson, and V.K. Kuchroo IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice J. Immunol. 173 2004 828 834
5. P. Anderson Post-transcriptional control of cytokine production Nat. Immunol. 9 2008 353 359
6. F. Apparailly, C. Verwaerde, C. Jacquet, C. Auriault, J. Sany, and C. Jorgensen Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis J. Immunol. 160 1998 5213 5220
7. T. Arimoto, D.Y. Choi, X. Lu, M. Liu, X.V. Nguyen, N. Zheng, C.A. Stewart, H.C. Kim, and G. Bing Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra Neurobiol. Aging 28 2007 894 906
8. S. Ayhan, C. Tugay, T. Ortak, R. Prayson, M. Parker, M. Siemionow, and F.A. Papay Effect of bioabsorbable osseous fixation materials on dura mater and brain tissue Plastic Reconstr. Surg. 109 2002 1333 1337
9. A. Bachis, A.M. Colangelo, S. Vicini, P.P. Doe, M.A. De Bernardi, G. Brooker, and I. Mocchetti Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity J. Neurosci. 21 2001 3104 3112
10. M.M. Backonja, C.L. Coe, D.A. Muller, and K. Schell Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients J. Neuroimmunol. 195 2008 157 163
11. V. Balasingam, and V.W. Yong Attenuation of astroglial reactivity by interleukin-10 J. Neurosci. 16 1996 2945 2955
12. C. Ball, S. Vigues, C.K. Gee, S. Poole, and A.F. Bristow Rat interleukin-10: production and characterisation of biologically active protein in a recombinant bacterial expression system Eur. Cytokine Netw. 12 2001 187 193
13. F.J. Barrat, D.J. Cua, A. Boonstra, D.F. Richards, C. Crain, H.F. Savelkoul, R. de Waal-Malefyt, R.L. Coffman, C.M. Hawrylowicz, and A. O'Garra In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines J. Exp. Med. 195 2002 603 616
14. H. Batoulis, M.S. Recks, K. Addicks, and S. Kuerten Experimental autoimmune encephalomyelitis - achievements and prospective advances APMIS Acta Pathol. Microbiol. Immunol. Scand. 119 2011 819 830
15. E. Bettelli, M.P. Das, E.D. Howard, H.L. Weiner, R.A. Sobel, and V.K. Kuchroo IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice J. Immunol. 161 1998 3299 3306
16. A.S. Beutler, and M. Reinhardt AAV for pain: steps towards clinical translation Gene Ther. 16 2009 461 469
17. M. Bialecka, G. Klodowska-Duda, M. Kurzawski, J. Slawek, A. Gorzkowska, G. Opala, P. Bialecki, L. Sagan, and M. Drozdzik Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients Park. Relat. Disord. 14 2008 636 640
18. M. Bialecka, G. Klodowska-Duda, M. Kurzawski, J. Slawek, G. Opala, P. Bialecki, K. Safranow, and M. Drozdzik Interleukin-10 gene polymorphism in Parkinson's disease patients Arch. Med. Res. 38 2007 858 863
19. A. Boonstra, R. Rajsbaum, M. Holman, R. Marques, C. Asselin-Paturel, J.P. Pereira, E.E. Bates, S. Akira, P. Vieira, Y.J. Liu, G. Trinchieri, and A. O'Garra Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals J. Immunol. 177 2006 7551 7558
20. S. Botha-Scheepers, I. Watt, E. Slagboom, A.J. de Craen, I. Meulenbelt, F.R. Rosendaal, F.C. Breedveld, T.W. Huizinga, and M. Kloppenburg Innate production of tumour necrosis factor alpha and interleukin 10 is associated with radiological progression of knee osteoarthritis Ann. Rheum. Dis. 67 2008 1165 1169
21. Z.S. Boyd, A. Kriatchko, J. Yang, N. Agarwal, M.B. Wax, and R.V. Patil Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress Invest. Ophthalmol. Vis. Sci. 44 2003 5206 5211
22. B. Brodacki, J. Staszewski, B. Toczylowska, E. Kozlowska, N. Drela, M. Chalimoniuk, and A. Stepien Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism Neurosci. Lett. 441 2008 158 162
23. B. Cannella, Y.L. Gao, C. Brosnan, and C.S. Raine IL-10 fails to abrogate experimental autoimmune encephalomyelitis J. Neurosci. Res. 45 1996 735 746
24. S. Cao, X. Zhang, J.P. Edwards, and D.M. Mosser NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages J. Biol. Chem. 281 2006 26041 26050
25. K.R. Chaudhuri, D.G. Healy, and A.H. Schapira Non-motor symptoms of Parkinson's disease: diagnosis and management Lancet Neurol. 5 2006 235 245
26. H. Chi, S.P. Barry, R.J. Roth, J.J. Wu, E.A. Jones, A.M. Bennett, and R.A. Flavell Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses Proc. Natl. Acad. Sci. U. S. A. 103 2006 2274 2279
27. K. Chu, X. Zhou, and B.Y. Luo Cytokine gene polymorphisms and Parkinson's disease: a meta-analysis. The Canadian journal of neurological sciences Le J. Can. Sci. Neurol. 39 2012 58 64
28. A. Compston, and A. Coles Multiple sclerosis Lancet 372 2008 1502 1517
29. A.L. Croxford, F.C. Kurschus, and A. Waisman Mouse models for multiple sclerosis: historical facts and future implications Biochim. Biophys. Acta 1812 2011 177 183
30. J.L. Croxford, M. Feldmann, Y. Chernajovsky, and D. Baker Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system J. Immunol. 166 2001 4124 4130
31. D.J. Cua, H. Groux, D.R. Hinton, S.A. Stohlman, and R.L. Coffman Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis J. Exp. Med. 189 1999 1005 1010
32. D.J. Cua, B. Hutchins, D.M. LaFace, S.A. Stohlman, and R.L. Coffman Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis J. Immunol. 166 2001 602 608
33. A.F. de Vos, M. van Meurs, H.P. Brok, L.A. Boven, R.Q. Hintzen, P. van der Valk, R. Ravid, S. Rensing, L. Boon, B.A. t Hart, and J.D. Laman Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs J. Immunol. 169 2002 5415 5423
34. E.C. Dengler, L.A. Alberti, B.N. Bowman, A.A. Kerwin, J.L. Wilkerson, D.R. Moezzi, E. Limanovich, J.A. Wallace, and E.D. Milligan Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain J. Neuroinflammation 11 2014 92
35. C.D. Dijkstra, E.A. Dopp, P. Joling, and G. Kraal The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3 Immunology 54 1985 589 599
36. Y. Ding, L. Qin, D. Zamarin, S.V. Kotenko, S. Pestka, K.W. Moore, and J.S. Bromberg Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation J. Immunol. 167 2001 6884 6892
37. G. Disanto, and S.V. Ramagopalan Similar genetics of adult and pediatric MS: age is just a number Neurology 81 2013 1974 1975
38. A. Dominguez-Soto, E. Sierra-Filardi, A. Puig-Kroger, B. Perez-Maceda, F. Gomez-Aguado, M.T. Corcuera, P. Sanchez-Mateos, and A.L. Corbi Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10 J. Immunol. 186 2011 2192 2200
39. M. Duddy, M. Niino, F. Adatia, S. Hebert, M. Freedman, H. Atkins, H.J. Kim, and A. Bar-Or Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis J. Immunol. 178 2007 6092 6099
40. J.S. Duffield The inflammatory macrophage: a story of Jekyll and Hyde Clin. Sci. 104 2003 27 38
41. J.C. Fernandes, J. Martel-Pelletier, and J.P. Pelletier The role of cytokines in osteoarthritis pathophysiology Biorheology 39 2002 237 246
42. D.S. Finbloom, and K.D. Winestock IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes J. Immunol. 155 1995 1079 1090
43. D.F. Fiorentino, M.W. Bond, and T.R. Mosmann Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J. Exp. Med. 170 1989 2081 2095
44. S. Franchi, A.E. Valsecchi, E. Borsani, P. Procacci, D. Ferrari, C. Zalfa, P. Sartori, L.F. Rodella, A. Vescovi, S. Maione, F. Rossi, P. Sacerdote, M. Colleoni, and A.E. Panerai Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy Pain 153 2012 850 861
45. A. George, C. Kleinschnitz, M. Zelenka, J. Brinkhoff, G. Stoll, and C. Sommer Wallerian degeneration after crush or chronic constriction injury of rodent sciatic nerve is associated with a depletion of endoneurial interleukin-10 protein Exp. Neurol. 188 2004 187 191
46. D. Gomez-Nicola, B. Valle-Argos, M. Suardiaz, J.S. Taylor, and M. Nieto-Sampedro Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration J. Neurochem. 107 2008 1741 1752
47. P.M. Grace, P.E. Rolan, and M.R. Hutchinson Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain Brain Behav. Immun. 25 2011 1322 1332
48. P.M.L.L.C. Grace, K.A. Strand, J.P. Christianson, J.G. Flyer, K.R. Penzkover, Y. Zhang, S.F. Maier, A. van Dam, M.J. Mahoney, and L.R. Watkins Intrathecal IL-10 gene therapy (XT-101) attenuates multiple sclerosis-like symptoms in a rat model of experimental autoimmune encephalomyelitis (EAE) The Society for Neuroscience Annual Meeting, New Orleans, LA 2012 767 703/U711
49. S. Grinberg, G. Hasko, D. Wu, and S.J. Leibovich Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype Am. J. Pathol. 175 2009 2439 2453
50. S.I. Gringhuis, J. den Dunnen, M. Litjens, B. van Het Hof, Y. van Kooyk, and T.B. Geijtenbeek C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB Immunity 26 2007 605 616
51. H. Groux, M. Bigler, J.E. de Vries, and M.G. Roncarolo Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells J. Exp. Med. 184 1996 19 29
52. E. Guntz, H. Dumont, E. Pastijn, K. d'Exaerde Ade, K. Azdad, M. Sosnowski, S.N. Schiffmann, and D. Gall Expression of adenosine A 2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents Anesth. Analg. 106 2008 1882 1889
53. J. Gutierrez, S. Raju, J.P. Riley, and N.M. Boulis Introduction to neuropathic pain Syndromes Neurosurg. Clin. N. Am. 25 2014 639 662
54. S. Gyoneva, A.G. Orr, and S.F. Traynelis Differential regulation of microglial motility by ATP/ADP and adenosine Park. Relat. Disord. 15 Suppl. 3 2009 S195 S199
55. A. Hakansson, L. Westberg, S. Nilsson, S. Buervenich, A. Carmine, B. Holmberg, O. Sydow, L. Olson, B. Johnels, E. Eriksson, and H. Nissbrandt Investigation of genes coding for inflammatory components in Parkinson's disease Mov. Disord. Off. J. Mov. Disord. Soc. 20 2005 569 573
56. M. Hammer, J. Mages, H. Dietrich, F. Schmitz, F. Striebel, P.J. Murray, H. Wagner, and R. Lang Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10 Eur. J. Immunol. 35 2005 2991 3001
57. E.G. Hansen, T.H. Duedahl, J. Romsing, K.L. Hilsted, and J.B. Dahl Intra-operative remifentanil might influence pain levels in the immediate post-operative period after major abdominal surgery Acta Anaesthesiol. Scand. 49 2005 1464 1470
58. G. Hasko, C. Szabo, Z.H. Nemeth, V. Kvetan, S.M. Pastores, and E.S. Vizi Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice J. Immunol. 157 1996 4634 4640
59. C.M. Hawrylowicz, and A. O'Garra Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma Nat. Rev. Immunol. 5 2005 271 283
60. Z. He, Q. Guo, M. Xiao, C. He, and W. Zou Intrathecal lentivirus-mediated transfer of interleukin-10 attenuates chronic constriction injury-induced neuropathic pain through modulation of spinal high-mobility group box 1 in rats Pain Physician 16 2013 E615 E625
61. M.L. Hedley Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors Expert Opin. Biol. Ther. 3 2003 903 910
62. I.C. Helmark, U.R. Mikkelsen, J. Borglum, A. Rothe, M.C. Petersen, O. Andersen, H. Langberg, and M. Kjaer Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial Arthritis Res. Ther. 12 2010 R126
63. D. Hesse, M. Krakauer, H. Lund, H.B. Sondergaard, S.J. Limborg, P.S. Sorensen, and F. Sellebjerg Disease protection and interleukin-10 induction by endogenous interferon-beta in multiple sclerosis? Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc. 18 2011 266 272
64. H. Honda, H. Kimura, and A. Rostami Demonstration and phenotypic characterization of resident macrophages in rat skeletal muscle Immunology 70 1990 272 277
65. X. Hu, P.K. Paik, J. Chen, A. Yarilina, L. Kockeritz, T.T. Lu, J.R. Woodgett, and L.B. Ivashkiv IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins Immunity 24 2006 563 574
66. S. Hulshof, L. Montagne, C.J. De Groot, and P. Van Der Valk Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions Glia 38 2002 24 35
67. M.R. Hutchinson, S.T. Bland, K.W. Johnson, K.C. Rice, S.F. Maier, and L.R. Watkins Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward ScientificWorldJournal 7 2007 98 111
68. J. Imitola, T. Chitnis, and S.J. Khoury Cytokines in multiple sclerosis: from bench to bedside Pharmacol. Ther. 106 2005 163 177
69. J. Infante, I. Garcia-Gorostiaga, P. Sanchez-Juan, C. Sanchez-Quintana, J.L. Gurpegui, E. Rodriguez-Rodriguez, I. Mateo, J. Berciano, and O. Combarros Inflammation-related genes and the risk of Parkinson's disease: a multilocus approach Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc. 15 2008 431 433
70. S. Issazadeh, J.C. Lorentzen, M.I. Mustafa, B. Hojeberg, A. Mussener, and T. Olsson Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta J. Neuroimmunol. 69 1996 103 115
71. R. Jancalek, I. Svizenska, I. Klusakova, and P. Dubovy Bilateral changes of IL-10 protein in lumbar and cervical dorsal root ganglia following proximal and distal chronic constriction injury of peripheral nerve Neurosci. Lett. 501 2011 86 91
72. J. Jankovic Parkinson's disease: clinical features and diagnosis J. Neurol. Neurosurg. Psychiatry 79 2008 368 376
73. M.P. Jensen, C.M. Kuehn, D. Amtmann, and D.D. Cardenas Symptom burden in persons with spinal cord injury Arch. Phys. Med. Rehabilitation 88 2007 638 645
74. A. Joss, M. Akdis, A. Faith, K. Blaser, and C.A. Akdis IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway Eur. J. Immunol. 30 2000 1683 1690
75. Y. Kaneda Gene therapy: a battle against biological barriers Curr. Mol. Med. 1 2001 493 499
76. A.J. Kastin, V. Akerstrom, and W. Pan Interleukin-10 as a CNS therapeutic: the obstacle of the blood-brain/blood-spinal cord barrier Brain Res. Mol. brain Res. 114 2003 168 171
77. P.D. Katsikis, C.Q. Chu, F.M. Brennan, R.N. Maini, and M. Feldmann Immunoregulatory role of interleukin 10 in rheumatoid arthritis J. Exp. Med. 179 1994 1517 1527
78. T. Kawai, and S. Akira TLR signaling Semin. Immunol. 19 2007 24 32
79. S.J. Kenealy, M.A. Pericak-Vance, and J.L. Haines The genetic epidemiology of multiple sclerosis J. Neuroimmunol. 143 2003 7 12
80. M.K. Kennedy, D.S. Torrance, K.S. Picha, and K.M. Mohler Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery J. Immunol. 149 1992 2496 2505
81. A. Keravala, E.R. Lechman, J. Nash, Z. Mi, and P.D. Robbins Human, viral or mutant human IL-10 expressed after local adenovirus-mediated gene transfer are equally effective in ameliorating disease pathology in a rabbit knee model of antigen-induced arthritis Arthritis Res. Ther. 8 2006 R91
82. H. Kettenmann, U.K. Hanisch, M. Noda, and A. Verkhratsky Physiology of microglia Physiol. Rev. 91 2011 461 553
83. N.D. Khoa, M.C. Montesinos, A.B. Reiss, D. Delano, N. Awadallah, and B.N. Cronstein Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells J. Immunol. 167 2001 4026 4032
84. K. Kim, S.G. Lee, T.P. Kegelman, Z.Z. Su, S.K. Das, R. Dash, S. Dasgupta, P.M. Barral, M. Hedvat, P. Diaz, J.C. Reed, J.L. Stebbins, M. Pellecchia, D. Sarkar, and P.B. Fisher Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics J. Cell. Physiol. 226 2011 2484 2493
85. K.N. Kim, S. Watanabe, Y. Ma, S. Thornton, E.H. Giannini, and R. Hirsch Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer J. Immunol. 164 2000 1576 1581
86. T. Kiyota, K.L. Ingraham, R.J. Swan, M.T. Jacobsen, S.J. Andrews, and T. Ikezu AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice Gene Ther. 19 2012 724 733
87. B. Koppelman, J.J. Neefjes, J.E. de Vries, and R. de Waal Malefyt Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling Immunity 7 1997 861 871
88. P. Lacy, and J.L. Stow Cytokine release from innate immune cells: association with diverse membrane trafficking pathways Blood 118 2011 9 18
89. F. Lagarce, N. Faisant, J.C. Desfontis, L. Marescaux, F. Gautier, J. Richard, P. Menei, and J.P. Benoit Baclofen-loaded microspheres in gel suspensions for intrathecal drug delivery: in vitro and in vivo evaluation Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahr. e.V 61 2005 171 180
90. F. Lagarce, P. Renaud, N. Faisant, G. Nicolas, A. Cailleux, J. Richard, P. Menei, and J.P. Benoit Baclofen-loaded microspheres: preparation and efficacy testing in a new rabbit model Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahr. e.V 59 2005 449 459
91. D. Lau, S.E. Harte, T.J. Morrow, S. Wang, M. Mata, and D.J. Fink Herpes simplex virus vector-mediated expression of interleukin-10 reduces below-level central neuropathic pain after spinal cord injury Neurorehabilitation Neural Repair 26 2012 889 897
92. E.R. Lechman, D. Jaffurs, S.C. Ghivizzani, A. Gambotto, I. Kovesdi, Z. Mi, C.H. Evans, and P.D. Robbins Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees J. Immunol. 163 1999 2202 2208
93. A. Ledeboer, J.J. Breve, A. Wierinckx, S. van der Jagt, A.F. Bristow, J.E. Leysen, F.J. Tilders, and A.M. Van Dam Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells Eur. J. Neurosci. 16 2002 1175 1185
94. A. Ledeboer, B.M. Jekich, E.M. Sloane, J.H. Mahoney, S.J. Langer, E.D. Milligan, D. Martin, S.F. Maier, K.W. Johnson, L.A. Leinwand, R.A. Chavez, and L.R. Watkins Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats Brain Behav. Immun. 21 2007 686 698
95. B.S. Lee, I.G. Jun, S.H. Kim, and J.Y. Park Intrathecal gabapentin increases interleukin-10 expression and inhibits pro-inflammatory cytokine in a rat model of neuropathic pain J. Korean Med. Sci. 28 2013 308 314
96. D. Li, Q. He, R. Li, X. Xu, B. Chen, and A. Xie Interleukin-10 promoter polymorphisms in Chinese patients with Parkinson's disease Neurosci. Lett. 513 2012 183 186
97. L. Li, J.F. Elliott, and T.R. Mosmann IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity J. Immunol. 153 1994 3967 3978
98. A.A. Link, T. Kino, J.A. Worth, J.L. McGuire, M.L. Crane, G.P. Chrousos, R.L. Wilder, and I.J. Elenkov Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes J. Immunol. 164 2000 436 442
99. J.T. Liou, F.C. Liu, C.C. Mao, Y.S. Lai, and Y.J. Day Inflammation confers dual effects on nociceptive processing in chronic neuropathic pain model Anesthesiology 114 2011 660 672
100. M. Locati, A. Mantovani, and A. Sica Macrophage activation and polarization as an adaptive component of innate immunity Adv. Immunol. 120 2013 163 184
101. L.C. Loram, J.A. Harrison, E.M. Sloane, M.R. Hutchinson, P. Sholar, F.R. Taylor, D. Berkelhammer, B.D. Coats, S. Poole, E.D. Milligan, S.F. Maier, J. Rieger, and L.R. Watkins Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain J. Neurosci. 29 2009 14015 14025
102. L.C. Loram, F.R. Taylor, K.A. Strand, J.A. Harrison, R. Rzasalynn, P. Sholar, J. Rieger, S.F. Maier, and L.R. Watkins Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling Brain Behav. Immun. 33 2013 112 122
103. E. Lubberts, L.A. Joosten, L. Van Den Bersselaar, M.M. Helsen, A.C. Bakker, Z. Xing, C.D. Richards, and W.B. Van Den Berg Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw Clin. Exp. Immunol. 120 2000 375 383
104. Y. Ma, S. Thornton, L.E. Duwel, G.P. Boivin, E.H. Giannini, J.M. Leiden, J.A. Bluestone, and R. Hirsch Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer J. Immunol. 161 1998 1516 1524
105. L.J. Maccoux, F. Salway, P.J. Day, and D.N. Clements Expression profiling of select cytokines in canine osteoarthritis tissues Veterinary Immunol. Immunopathol. 118 2007 59 67
106. M.A. Macleod, G.E. Stewart, M. Zeidler, R. Will, and R. Knight Sensory features of variant Creutzfeldt-Jakob disease J. Neurol. 249 2002 706 711
107. A.M. Malfait, C.B. Little, and J.J. McDougall A commentary on modelling osteoarthritis pain in small animals Osteoarthr. Cartilage/OARS Osteoarthr. Res. Soc. 21 2013 1316 1326
108. R.A. Marrie Environmental risk factors in multiple sclerosis aetiology Lancet Neurol. 3 2004 709 718
109. J. Martel-Pelletier, N. Alaaeddine, and J.P. Pelletier Cytokines and their role in the pathophysiology of osteoarthritis Front. Biosci. J. Virtual Libr. 4 1999 D694 D703
110. I. Martinez-Forero, R. Garcia-Munoz, S. Martinez-Pasamar, S. Inoges, A. Lopez-Diaz de Cerio, R. Palacios, J. Sepulcre, B. Moreno, Z. Gonzalez, B. Fernandez-Diez, I. Melero, M. Bendandi, and P. Villoslada IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis Eur. J. Immunol. 38 2008 576 586
111. E. Mazzon, E. Esposito, D. Impellizzeri, R. DI Paola, A. Melani, P. Bramanti, F. Pedata, and S. Cuzzocrea CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis J. Rheumatol. 38 2011 2119 2129
112. K.K. McKinstry, T.M. Strutt, A. Buck, J.D. Curtis, J.P. Dibble, G. Huston, M. Tighe, H. Hamada, S. Sell, R.W. Dutton, and S.L. Swain IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge J. Immunol. 182 2009 7353 7363
113. M. Menza, R.D. Dobkin, H. Marin, M.H. Mark, M. Gara, K. Bienfait, A. Dicke, and A. Kusnekov The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease Psychosomatics 51 2010 474 479
114. C. Meuli-Simmen, Y. Liu, T.T. Yeo, D. Liggitt, G. Tu, T. Yang, M. Meuli, S. Knauer, T.D. Heath, F.M. Longo, and R.J. Debs Gene expression along the cerebral-spinal axis after regional gene delivery Hum. Gene Ther. 10 1999 2689 2700
115. J. Mika, M. Korostynski, D. Kaminska, A. Wawrzczak-Bargiela, M. Osikowicz, W. Makuch, R. Przewlocki, and B. Przewlocka Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model Pain 138 2008 587 597
116. E.D. Milligan, S.J. Langer, E.M. Sloane, L. He, J. Wieseler-Frank, K. O'Connor, D. Martin, J.R. Forsayeth, S.F. Maier, K. Johnson, R.A. Chavez, L.A. Leinwand, and L.R. Watkins Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10 Eur. J. Neurosci. 21 2005 2136 2148
117. E.D. Milligan, A. Ledeboer, E.M. Sloane, D.A. Busha, S.F. Maier, and L.R. Watkins Glially driven enhancement of pain and its control by anti-inflammatory cytokines J.A. DeLeo, L.S. Sorkin, L.R. Watkins, Immune and Glial Regulation of Pain 2007 IASP Press Seattle 319 340
118. E.D. Milligan, E.M. Sloane, S.J. Langer, P.E. Cruz, M. Chacur, L. Spataro, J. Wieseler-Frank, S.E. Hammack, S.F. Maier, T.R. Flotte, J.R. Forsayeth, L.A. Leinwand, R. Chavez, and L.R. Watkins Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10 Mol. Pain 1 2005 9
119. E.D. Milligan, E.M. Sloane, S.J. Langer, T.S. Hughes, B.M. Jekich, M.G. Frank, J.H. Mahoney, L.H. Levkoff, S.F. Maier, P.E. Cruz, T.R. Flotte, K.W. Johnson, M.M. Mahoney, R.A. Chavez, L.A. Leinwand, and L.R. Watkins Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain Pain 126 2006 294 308
120. E.D. Milligan, R.G. Soderquist, S.M. Malone, J.H. Mahoney, T.S. Hughes, S.J. Langer, E.M. Sloane, S.F. Maier, L.A. Leinwand, L.R. Watkins, and M.J. Mahoney Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain Neuron Glia Biol. 2 2006 293 308
121. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu. Rev. Immunol. 19 2001 683 765
122. V. Moos, S. Fickert, B. Muller, U. Weber, and J. Sieper Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage J. Rheumatol. 26 1999 870 879
123. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat. Rev. Immunol. 8 2008 958 969
124. P.J. Murray, and T.A. Wynn Protective and pathogenic functions of macrophage subsets Nat. Rev. Immunol. 11 2011 723 737
125. L. Nagelkerken, B. Blauw, and M. Tielemans IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice Int. Immunol. 9 1997 1243 1251
126. S. Naundorf, M. Schroder, C. Hoflich, N. Suman, H.D. Volk, and G. Grutz IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells Eur. J. Immunol. 39 2009 1066 1077
127. Z.H. Nemeth, C.S. Lutz, B. Csoka, E.A. Deitch, S.J. Leibovich, W.C. Gause, M. Tone, P. Pacher, E.S. Vizi, and G. Hasko Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism J. Immunol. 175 2005 8260 8270
128. K. Nie, Y. Zhang, R. Gan, L. Wang, J. Zhao, Z. Huang, and H. Tang Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population Neurosci. Lett. 541 2013 111 115
129. A. Nouel, Q. Simon, C. Jamin, J.O. Pers, and S. Hillion Regulatory B cells: an exciting target for future therapeutics in Transplantation Front. Immunol. 5 2014 11
130. A. O'Garra, and P. Vieira T(H)1 cells control themselves by producing interleukin-10 Nat. Rev. Immunol. 7 2007 425 428
131. K. Okamoto, D.P. Martin, J.D. Schmelzer, Y. Mitsui, and P.A. Low Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain Exp. Neurol. 169 2001 386 391
132. D.W. Pack, A.S. Hoffman, S. Pun, and P.S. Stayton Design and development of polymers for gene delivery Nature Rev. Drug Discov. 4 2005 581 593
133. E. Pascale, E. Passarelli, C. Purcaro, A.R. Vestri, A. Fakeri, R. Guglielmi, F. Passarelli, and G. Meco Lack of association between IL-1beta, TNF-alpha, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort Acta Neurol. Scand. 124 2011 176 181
134. M. Perez-Aso, J.L. Feig, A. Mediero, and B.N. Cronstein Adenosine A2A receptor and TNF-alpha regulate the circadian machinery of the human monocytic THP-1 cells Inflammation 36 2013 152 162
135. M.M. Polfliet, P.H. Goede, E.M. van Kesteren-Hendrikx, N. van Rooijen, C.D. Dijkstra, and T.K. van den Berg A method for the selective depletion of perivascular and meningeal macrophages in the central nervous system J. Neuroimmunol. 116 2001 188 195
136. M.J. Powell, S.A. Thompson, Y. Tone, H. Waldmann, and M. Tone Posttranscriptional regulation of IL-10 gene expression through sequences in the 3'-untranslated region J. Immunol. 165 2000 292 296
137. L. Qian, M.L. Block, S.J. Wei, C.F. Lin, J. Reece, H. Pang, B. Wilson, J.S. Hong, and P.M. Flood Interleukin-10 protects lipopolysaccharide-induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase J. Pharmacol. Exp. Ther. 319 2006 44 52
138. L. Qian, J.S. Hong, and P.M. Flood Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10 J. Neural Transm. Suppl. 2006 367 371
139. S.S. Rao, L.A. Hofmann, and A. Shakil Parkinson's disease: diagnosis and treatment Am. Fam. Physician 74 2006 2046 2054
140. U. Reineke, J. Schneider-Mergener, R.W. Glaser, R.D. Stigler, M. Seifert, H.D. Volk, and R. Sabat Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope J. Mol. Recognit. 12 1999 242 248
141. M. Rentzos, C. Nikolaou, E. Andreadou, G.P. Paraskevas, A. Rombos, M. Zoga, A. Tsoutsou, F. Boufidou, E. Kapaki, and D. Vassilopoulos Circulating interleukin-10 and interleukin-12 in Parkinson's disease Acta Neurol. Scand. 119 2009 332 337
142. P. Rieckmann, M. Albrecht, B. Kitze, T. Weber, H. Tumani, A. Broocks, W. Luer, and S. Poser Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis Neurology 44 1994 1523 1526
143. N. Riyazi, E. Slagboom, A.J. de Craen, I. Meulenbelt, J.J. Houwing-Duistermaat, H.M. Kroon, D. van Schaardenburg, F.R. Rosendaal, F.C. Breedveld, T.W. Huizinga, and M. Kloppenburg Association of the risk of osteoarthritis with high innate production of interleukin-1beta and low innate production of interleukin-10 ex vivo, upon lipopolysaccharide stimulation Arthritis Rheum. 52 2005 1443 1450
144. N.C. Rogers, E.C. Slack, A.D. Edwards, M.A. Nolte, O. Schulz, E. Schweighoffer, D.L. Williams, S. Gordon, V.L. Tybulewicz, G.D. Brown, and C. Reis e Sousa Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins Immunity 22 2005 507 517
145. M.G. Roncarolo, S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M.K. Levings Interleukin-10-secreting type 1 regulatory T cells in rodents and humans Immunol. Rev. 212 2006 28 50
146. O. Rott, B. Fleischer, and E. Cash Interleukin-10 prevents experimental allergic encephalomyelitis in rats Eur. J. Immunol. 24 1994 1434 1440
147. M.C. Rowbotham, and H.L. Fields The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia Brain J. Neurol. 119 Pt 2 1996 347 354
148. R. Sabat, G. Grutz, K. Warszawska, S. Kirsch, E. Witte, K. Wolk, and J. Geginat Biology of interleukin-10 Cytokine Growth Factor Rev. 21 2010 331 344
149. F. Salaffi, A. Ciapetti, and M. Carotti The sources of pain in osteoarthritis: a pathophysiological review Reumatismo 66 2014 57 71
150. J.C. Salengros, I. Huybrechts, A. Ducart, D. Faraoni, C. Marsala, L. Barvais, M. Cappello, and E. Engelman Different anesthetic techniques associated with different incidences of chronic post-thoracotomy pain: low-dose remifentanil plus presurgical epidural analgesia is preferable to high-dose remifentanil with postsurgical epidural analgesia J. Cardiothorac. Vasc. Anesth. 24 2010 608 616
151. E.B. Samoilova, J.L. Horton, and Y. Chen Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery Cell. Immunol. 188 1998 118 124
152. M. Saraiva, J.R. Christensen, M. Veldhoen, T.L. Murphy, K.M. Murphy, and A. O'Garra Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose Immunity 31 2009 209 219
153. M. Saraiva, and A. O'Garra The regulation of IL-10 production by immune cells Nat. Rev. Immunol. 10 2010 170 181
154. S. Schif-Zuck, G. Wildbaum, and N. Karin Coadministration of plasmid DNA constructs encoding an encephalitogenic determinant and IL-10 elicits regulatory T cell-mediated protective immunity in the central nervous system J. Immunol. 177 2006 8241 8247
155. N. Schuetze, S. Schoeneberger, U. Mueller, M.A. Freudenberg, G. Alber, and R.K. Straubinger IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages Int. Immunol. 17 2005 649 659
156. L.N. Schulte, A. Eulalio, H.J. Mollenkopf, R. Reinhardt, and J. Vogel Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family EMBO J. 30 2011 1977 1989
157. J. Schwenkgrub, I. Joniec-Maciejak, A. Sznejder-Pacholek, A. Wawer, A. Ciesielska, K. Bankiewicz, A. Czlonkowska, and A. Czlonkowski Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease Pharmacol. Reports P. R. 65 2013 44 49
158. M.G. Sebestyen, J.J. Ludtke, M.C. Bassik, G. Zhang, V. Budker, E.A. Lukhtanov, J.E. Hagstrom, and J.A. Wolff DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA Nat. Biotechnol. 16 1998 80 85
159. D. Sendil, I.M. Bonney, D.B. Carr, A.W. Lipkowski, D.L. Wise, and V. Hasirci Antinociceptive effects of hydromorphone, bupivacaine and biphalin released from PLGA polymer after intrathecal implantation in rats Biomaterials 24 2003 1969 1976
160. A. Sharma, M. Kumar, J. Aich, M. Hariharan, S.K. Brahmachari, A. Agrawal, and B. Ghosh Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a Proc. Natl. Acad. Sci. U. S. A. 106 2009 5761 5766
161. L. Sharma, D. Kapoor, and S. Issa Epidemiology of osteoarthritis: an update Curr. Opin. Rheumatol. 18 2006 147 156
162. S. Sharma, B. Yang, X. Xi, J.C. Grotta, J. Aronowski, and S.I. Savitz IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways Brain Res. 1373 2011 189 194
163. K.F. Shen, H.Q. Zhu, X.H. Wei, J. Wang, Y.Y. Li, R.P. Pang, and X.G. Liu Interleukin-10 down-regulates voltage gated sodium channels in rat dorsal root ganglion neurons Exp. Neurol. 247 2013 466 475
164. L. Shi, G.P. Tang, S.J. Gao, Y.X. Ma, B.H. Liu, Y. Li, J.M. Zeng, Y.K. Ng, K.W. Leong, and S. Wang Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord Gene Ther. 10 2003 1179 1188
165. R. Shrestha, S. Shakya Shrestha, O. Millingtona, J. Brewer, and T. Bushell Immune responses in neurodegenerative diseases Kathmandu Univ. Med. J. 12 2014 67 76
166. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J. Clin. Investig. 122 2012 787 795
167. E.C. Slack, M.J. Robinson, P. Hernanz-Falcon, G.D. Brown, D.L. Williams, E. Schweighoffer, V.L. Tybulewicz, and C. Reis e Sousa Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan Eur. J. Immunol. 37 2007 1600 1612
168. E. Sloane, S. Langer, B. Jekich, J. Mahoney, T. Hughes, M. Frank, W. Seibert, G. Huberty, B. Coats, J. Harrison, D. Klinman, S. Poole, S. Maier, K. Johnson, R. Chavez, L.R. Watkins, L. Leinwand, and E. Milligan Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain Gene Ther. 16 2009 1210 1222
169. E. Sloane, A. Ledeboer, W. Seibert, B. Coats, M. van Strien, S.F. Maier, K.W. Johnson, R. Chavez, L.R. Watkins, L. Leinwand, E.D. Milligan, and A.M. Van Dam Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy Brain Behav. Immun. 23 2009 92 100
170. E.M. Sloane, R.G. Soderquist, S.F. Maier, M.J. Mahoney, L.R. Watkins, and E.D. Milligan Long-term control of neuropathic pain in a non-viral gene therapy paradigm Gene Ther. 16 2009 470 475
171. T.J. Smeets, M.C. Kraan, J. Versendaal, F.C. Breedveld, and P.P. Tak Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo J. Rheumatol. 26 1999 2089 2093
172. R.G. Soderquist, E.D. Milligan, J.A. Harrison, R.A. Chavez, K.W. Johnson, L.R. Watkins, and M.J. Mahoney PEGylation of interleukin-10 for the mitigation of enhanced pain states J. Biomed. Mater. Res. Part A 93 2010 1169 1179
173. R.G. Soderquist, E.M. Sloane, L.C. Loram, J.A. Harrison, E.C. Dengler, S.M. Johnson, L.D. Amer, C.S. Young, M.T. Lewis, S. Poole, M.G. Frank, L.R. Watkins, E.D. Milligan, and M.J. Mahoney Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration Pharm. Res. 27 2010 841 854
174. S. Spence, A. Fitzsimons, C.R. Boyd, J. Kessler, D. Fitzgerald, J. Elliott, J.N. Gabhann, S. Smith, A. Sica, E. Hams, S.P. Saunders, C.A. Jefferies, P.G. Fallon, D.F. McAuley, A. Kissenpfennig, and J.A. Johnston Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization Immunity 38 2013 66 78
175. R. Syto, N.J. Murgolo, E.H. Braswell, P. Mui, E. Huang, and W.T. Windsor Structural and biological stability of the human interleukin 10 homodimer Biochemistry 37 1998 16943 16951
176. N. Tanuma, T. Shin, and Y. Matsumoto Characterization of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats J. Neuroimmunol. 108 2000 171 180
177. F.I. Tarazi, Z. Sahli, M. Wolny, and S.A. Mousa Emerging therapies for Parkinson's disease: from bench to bedside Pharmacol. Ther. 144 2014 123 133
178. F.I. Tarazi, Z.T. Sahli, M. Wolny, and S.A. Mousa Emerging therapies for Parkinson's disease: from bench to bedside Pharmacol. Ther. 144 2014 123 133
179. R.L. Taruc-Uy, and S.A. Lynch Diagnosis and treatment of osteoarthritis Prim. Care 40 2013 821 836 (vii)
180. H.S. Taskinen, T. Olsson, A. Bucht, M. Khademi, L. Svelander, and M. Roytta Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA J. Neuroimmunol. 102 2000 17 25
181. R.S. Taylor Epidemiology of refractory neuropathic pain Pain Pract. Off. J. World Inst. Pain 6 2006 22 26
182. J. Thibodeau, M.C. Bourgeois-Daigneault, G. Huppe, J. Tremblay, A. Aumont, M. Houde, E. Bartee, A. Brunet, M.E. Gauvreau, A. de Gassart, E. Gatti, M. Baril, M. Cloutier, S. Bontron, K. Fruh, D. Lamarre, and V. Steimle Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes Eur. J. Immunol. 38 2008 1225 1230
183. E. Tolosa, G. Wenning, and W. Poewe The diagnosis of Parkinson's disease Lancet Neurol. 5 2006 75 86
184. C.M. Trevino, T. deRoon-Cassini, and K. Brasel Does opiate use in traumatically injured individuals worsen pain and psychological outcomes? J. Pain Off. J. Am. Pain Soc. 14 2013 424 430
185. E.A. Tukhovskaya, E.A. Turovsky, M.V. Turovskaya, S.G. Levin, A.N. Murashev, V.P. Zinchenko, and O.V. Godukhin Anti-inflammatory cytokine interleukin-10 increases resistance to brain ischemia through modulation of ischemia-induced intracellular Ca response Neurosci. Lett. 571 2014 55 60
186. M.V. Turovskaya, E.A. Turovsky, V.P. Zinchenko, S.G. Levin, and O.V. Godukhin Interleukin-10 modulates [Ca2+]i response induced by repeated NMDA receptor activation with brief hypoxia through inhibition of InsP(3)-sensitive internal stores in hippocampal neurons Neurosci. Lett. 516 2012 151 155
187. N. Uceyler, J.P. Rogausch, K.V. Toyka, and C. Sommer Differential expression of cytokines in painful and painless neuropathies Neurology 69 2007 42 49
188. A.H. van Boxel-Dezaire, S.C. Hoff, B.W. van Oosten, C.L. Verweij, A.M. Drager, H.J. Ader, J.C. van Houwelingen, F. Barkhof, C.H. Polman, and L. Nagelkerken Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis Ann. Neurol. 45 1999 695 703
189. L. van Gulik, S.J. Ahlers, E.M. van de Garde, P. Bruins, W.J. van Boven, D. Tibboel, E.P. van Dongen, and C.A. Knibbe Remifentanil during cardiac surgery is associated with chronic thoracic pain 1 yr after sternotomy Br. J. Anaesth. 109 2012 616 622
190. J. van Roon, S. Wijngaarden, F.P. Lafeber, C. Damen, J. van de Winkel, and J.W. Bijlsma Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation J. Rheumatol. 30 2003 648 651
191. F. Vincenzi, C. Corciulo, M. Targa, I. Casetta, M. Gentile, E. Granieri, P.A. Borea, P. Popoli, and K. Varani A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients Amyotroph. Lateral Scler. Frontotemporal Degener. 14 2013 406 413
192. F. Vincenzi, C. Corciulo, M. Targa, S. Merighi, S. Gessi, I. Casetta, M. Gentile, E. Granieri, P.A. Borea, and K. Varani Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated Eur. J. Immunol. 43 2013 2206 2216
193. R. Wagner, M. Janjigian, and R.R. Myers Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression Pain 74 1998 35 42
194. M.R. Walter, and T.L. Nagabhushan Crystal structure of interleukin 10 reveals an interferon gamma-like fold Biochemistry 34 1995 12118 12125
195. Y.C. Wang, F. He, F. Feng, X.W. Liu, G.Y. Dong, H.Y. Qin, X.B. Hu, M.H. Zheng, L. Liang, L. Feng, Y.M. Liang, and H. Han Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses Cancer Res. 70 2010 4840 4849
196. Z.H. Wang, X.Y. Zeng, S.P. Han, G.X. Fan, and J.Y. Wang Interleukin-10 of red nucleus plays anti-allodynia effect in neuropathic pain rats with spared nerve injury Neurochem. Res. 37 2012 1811 1819
197. L.R. Watkins, M.R. Hutchinson, K.C. Rice, and S.F. Maier The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia Trends Pharmacol. Sci. 30 2009 581 591
198. E. Waubant, L. Gee, P. Bacchetti, R. Sloan, A. Cotleur, R. Rudick, and D. Goodkin Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS J. Neuroimmunol. 112 2001 139 145
199. R.M. Weber-Nordt, J.K. Riley, A.C. Greenlund, K.W. Moore, J.E. Darnell, and R.D. Schreiber Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain J. Biol. Chem. 271 1996 27954 27961
200. J. Wehinger, F. Gouilleux, B. Groner, J. Finke, R. Mertelsmann, and R.M. Weber-Nordt IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes FEBS Lett. 394 1996 365 370
201. J.D. Whalen, E.L. Lechman, C.A. Carlos, K. Weiss, I. Kovesdi, J.C. Glorioso, P.D. Robbins, and C.H. Evans Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws J. Immunol. 162 1999 3625 3632
202. C.S. Whyte, E.T. Bishop, D. Ruckerl, S. Gaspar-Pereira, R.N. Barker, J.E. Allen, A.J. Rees, and H.M. Wilson Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function J. Leukoc. Biol. 90 2011 845 854
203. J.L. Wilkerson, K.R. Gentry, E.C. Dengler, J.A. Wallace, A.A. Kerwin, L.M. Armijo, M.N. Kuhn, G.A. Thakur, A. Makriyannis, and E.D. Milligan Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels Pain 153 2012 1091 1106
204. J.L. Wilkerson, K.R. Gentry, E.C. Dengler, J.A. Wallace, A.A. Kerwin, M.N. Kuhn, A.M. Zvonok, G.A. Thakur, A. Makriyannis, and E.D. Milligan Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia Brain Behav. 2 2012 155 177
205. W.T. Windsor, R. Syto, A. Tsarbopoulos, R. Zhang, J. Durkin, S. Baldwin, S. Paliwal, P.W. Mui, B. Pramanik, and P.P. Trotta Disulfide bond assignments and secondary structure analysis of human and murine interleukin 10 Biochemistry 32 1993 8807 8815
206. K. Wolk, S. Kunz, K. Asadullah, and R. Sabat Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168 2002 5397 5402
207. K. Wolk, S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat IL-22 increases the innate immunity of tissues Immunity 21 2004 241 254
208. K. Wolk, E. Witte, U. Reineke, K. Witte, M. Friedrich, W. Sterry, K. Asadullah, H.D. Volk, and R. Sabat Is there an interaction between interleukin-10 and interleukin-22? Genes. Immun. 6 2005 8 18
209. M.J. Wood, H.M. Charlton, K.J. Wood, K. Kajiwara, and A.P. Byrnes Immune responses to adenovirus vectors in the nervous system Trends Neurosci. 19 1996 497 501
210. B.G. Xiao, X.F. Bai, G.X. Zhang, and H. Link Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats J. Neuroimmunol. 84 1998 230 237
211. J. Yan, Q. Fu, L. Cheng, M. Zhai, W. Wu, L. Huang, and G. Du Inflammatory response in Parkinson's disease (Review) Mol. Med. Reports 10 2014 2223 2233
212. S.Q. Yao, Z.Z. Li, Q.Y. Huang, F. Li, Z.W. Wang, E. Augusto, J.C. He, X.T. Wang, J.F. Chen, and R.Y. Zheng Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis J. Neurochem. 123 2012 100 112
213. S.I. Yoon, B.C. Jones, N.J. Logsdon, B.D. Harris, A. Deshpande, S. Radaeva, B.A. Halloran, B. Gao, and M.R. Walter Structure and mechanism of receptor sharing by the IL-10R2 common chain Structure 18 2010 638 648
214. S.I. Yoon, N.J. Logsdon, F. Sheikh, R.P. Donnelly, and M.R. Walter Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex J. Biol. Chem. 281 2006 35088 35096
215. A. Yoshimura, T. Naka, and M. Kubo SOCS proteins, cytokine signalling and immune regulation Nat. Rev. Immunol. 7 2007 454 465
216. A. Zdanov Structural analysis of cytokines comprising the IL-10 family Cytokine Growth Factor Rev. 21 2010 325 330
217. A. Zdanov, C. Schalk-Hihi, A. Gustchina, M. Tsang, J. Weatherbee, and A. Wlodawer Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma Structure 3 1995 591 601
218. J. Zhang, X.Q. Shi, S. Echeverry, J.S. Mogil, Y. De Koninck, and S. Rivest Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain J. Neurosci. 27 2007 12396 12406
219. X. Zhang, Z. Mao, and C. Yu Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10 J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 22 2004 742 750
220. Z. Zhou, X. Peng, R. Insolera, D.J. Fink, and M. Mata Interleukin-10 provides direct trophic support to neurons J. Neurochem. 110 2009 1617 1627